title: Chemical angioplasty with spasmolytics for vasospasm after subarachnoid hemorrhage.
abstract: Clinically symptomatic vasospasm leading to delayed ischemic neurological deficits occurs in up to 30% of patients with subarachnoid hemorrhage (SAH). Vasospasm can result in a serious decline in clinical conditions of patients with SAH, yet the algorithm for vasospasm treatment and prevention remains unclear. Intra-arterial administration of vasodilators is one of the modalities used for vasospasm therapy.
  
  
  
  Over the last 7 years, we have treated 27 female and 7 male patients with vasospasm using intra-arterial administration of either nimodipine or milrinone; all had suffered aneurysm rupture. Of these patients, 28 were treated surgically (clip), and 6 patients had their aneurysm coiled. Spasmolytics were applied from day 2 to day 18 after rupture.
  
  
  
  Of the 53 procedures, angiographic improvement was documented in 92% of cases with a mean flow velocity decrease of 65 cm/s. Brain metabolism changes were monitored after the procedure. The highest level of immediate clinical improvement was observed in conscious patients with a focal neurological deficit (aphasia, hemiparesis). Overall clinical outcomes (Glasgow outcome scale, GOS) were as follows: GOS 5 (12 patients), GOS 4 (5 patients), GOS 3 (5 patients), GOS 2 (6 patients), and GOS 1 (6 patients).
  
  
  
  Intra-arterial administration of spasmolytics is a safe and potent method of vasospasm treatment. It is most effective when applied to conscious patients with a focal deficit. For unconscious patients, its therapeutic benefits are inconclusive. Patients in severe clinical states would further require use of other diagnostic tools such as multimodal brain monitoring to complement vasospasm therapy.
authors.affiliation: Department of Neurosurgery of the J.E. Purkinje University, Masaryk Hospital, Sociální péče 12A, Ústí nad Labem, 401 13, Czech Republic. ales.hejcl@gmail.com.|International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. ales.hejcl@gmail.com.|Department of Neurosurgery of the 1st Medical Faculty and the Central Military Hospital, Prague, Czech Republic. ales.hejcl@gmail.com.|Department of Tissue Culture and Stem Cells, Institute of Experimental Medicine ASCR, Prague, Czech Republic. ales.hejcl@gmail.com.
authors.forename: Aleš
authors.identifier: 0000-0002-9206-1980
authors.initials: A
authors.lastname: Hejčl
authors.affiliation: Department of Radiology, Masaryk Hospital, Ústí nad Labem, Czech Republic.
authors.forename: Filip
authors.initials: F
authors.lastname: Cihlář
authors.affiliation: Department of Radiology, Masaryk Hospital, Ústí nad Labem, Czech Republic.
authors.forename: Vojtěch
authors.initials: V
authors.lastname: Smolka
authors.affiliation: Department of Neurosurgery of the J.E. Purkinje University, Masaryk Hospital, Sociální péče 12A, Ústí nad Labem, 401 13, Czech Republic.|Department of Neurosurgery, University Hospital Pilsen, The Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic.
authors.forename: Petr
authors.initials: P
authors.lastname: Vachata
authors.affiliation: Department of Neurosurgery of the J.E. Purkinje University, Masaryk Hospital, Sociální péče 12A, Ústí nad Labem, 401 13, Czech Republic.
authors.forename: Robert
authors.initials: R
authors.lastname: Bartoš
authors.affiliation: Department of Anesthesiology, Perioperative Medicine and Intensive Care, J.E. Purkinje University, Masaryk Hospital, Ústí nad Labem, Czech Republic.
authors.forename: Jan
authors.initials: J
authors.lastname: Procházka
authors.affiliation: Department of Mathematics, Faculty of Science, J.E. Purkinje University, Ústí nad Labem, Czech Republic.
authors.forename: Jiří
authors.initials: J
authors.lastname: Cihlář
authors.affiliation: Department of Neurosurgery of the J.E. Purkinje University, Masaryk Hospital, Sociální péče 12A, Ústí nad Labem, 401 13, Czech Republic.
authors.forename: Martin
authors.initials: M
authors.lastname: Sameš
mesh_terms: D000328:Adult; D017130:Angioplasty / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009553:Nimodipine / Q000008:administration & dosage* / Q000627:therapeutic use; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D020301:Vasospasm, Intracranial / Q000188:drug therapy*
chemical_list: D014665:Vasodilator Agents; D009553:Nimodipine
keywords: Angiography; Cerebral vasospasm; Microdialysis; Milrinone; Nimodipine; Outcome; Spasmolytics; Transcranial dopplerometry